• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性离子型使君子氨酸受体激动剂AMPA在未成熟大鼠脑中是一种强效神经毒素。

The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain.

作者信息

McDonald J W, Trescher W H, Johnston M V

机构信息

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Brain Res. 1990 Aug 27;526(1):165-8. doi: 10.1016/0006-8993(90)90266-e.

DOI:10.1016/0006-8993(90)90266-e
PMID:1964108
Abstract

Direct unilateral intrastriatal stereotaxic injections of the selective ionotropic-type quisqualate receptor agonist, AMPA, in postnatal day 7 rats produced tonic-clonic seizure activity. Quantitative analysis of the severity of brain injury was assessed by comparison of the disparities in the weights of injected and contralateral cerebral hemispheres 3 days after the excitotoxin injection. The amount of AMPA that produced half-maximal brain injury was 9.5 nmol as assessed by comparison of disparities in cerebral hemisphere weights. In contrast, quisqualate was 26 times less potent. The marked susceptibility of the developing rat brain to AMPA toxicity may provide a useful model to assess the neuroprotective effectiveness and selectivity of ionotropic quisqualate receptor antagonists.

摘要

在出生后第7天的大鼠中,通过立体定位法向单侧纹状体内直接注射选择性离子型quisqualate受体激动剂AMPA,可产生强直阵挛性癫痫发作活动。在注射兴奋性毒素3天后,通过比较注射侧和对侧大脑半球的重量差异,对脑损伤的严重程度进行定量分析。通过比较大脑半球重量差异评估,产生半数最大脑损伤的AMPA量为9.5纳摩尔。相比之下,quisqualate的效力要低26倍。发育中的大鼠大脑对AMPA毒性的显著易感性,可能为评估离子型quisqualate受体拮抗剂的神经保护有效性和选择性提供一个有用的模型。

相似文献

1
The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain.选择性离子型使君子氨酸受体激动剂AMPA在未成熟大鼠脑中是一种强效神经毒素。
Brain Res. 1990 Aug 27;526(1):165-8. doi: 10.1016/0006-8993(90)90266-e.
2
Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development.在出生后早期发育过程中,大脑对AMPA诱导的兴奋性毒性的易感性会短暂达到峰值。
Brain Res. 1992 Jun 26;583(1-2):54-70. doi: 10.1016/s0006-8993(10)80009-5.
3
Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum.通过大鼠纹状体突触体上的D,L-α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体对多巴胺释放的突触前易化作用。
J Pharmacol Exp Ther. 1991 Nov;259(2):692-8.
4
Quisqualate receptors in epileptic fowl: the absence of coupling between quisqualate and N-methyl-D-aspartate receptors.
Eur J Pharmacol. 1990 Jan 3;175(1):85-91. doi: 10.1016/0014-2999(90)90156-z.
5
Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
Mol Pharmacol. 1991 Jun;39(6):745-53.
6
The effects of kainate and the glutamate agonist, AMPA, are not separable in rat neocortical cultures.
Neurosci Lett. 1992 Jul 6;141(1):57-60. doi: 10.1016/0304-3940(92)90333-3.
7
Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.非洲爪蟾卵母细胞中表达的兴奋性氨基酸受体:激动剂药理学
Mol Pharmacol. 1988 Sep;34(3):298-307.
8
Effects of thiol-reagents on [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes.硫醇试剂对[3H]α-氨基-3-羟基-5-甲基异恶唑-4-丙酸与大鼠端脑细胞膜结合的影响。
Mol Pharmacol. 1988 Aug;34(2):117-23.
9
Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography.定量放射自显影揭示大鼠脑(RS)-α-氨基-3-羟基-5-甲基异恶唑-4-丙酸受体的多种状态
Mol Pharmacol. 1992 May;41(5):832-8.
10
Neonatal striatal NADPH-diaphorase neurons are vulnerable to quisqualate and its analogue alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionate (AMPA).新生期纹状体的还原型辅酶Ⅱ黄递酶神经元对喹啉酸及其类似物α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)敏感。
Neurosci Lett. 1991 May 13;126(1):52-6. doi: 10.1016/0304-3940(91)90369-5.